The Global Capnography market is expanding quickly thanks to the tremendous technological advancements being made in the development of new-generation capnography devices. To put it into perspective, the market is currently valued at US$ 202.64 million but that number is expected to more-than double by 2016 at a CAGR of 20.17 percent.
Now let’s talk about some of these developments that have been have been impacting the world of capnography with such force!
Oridion’s Microstream was one of the first technology’s to create a revolution in the Global Capnography market. Microstream capnographs use laser-based MCS as the infrared emission source, instead of the conventional sensors used to detect EtCO2. Devices based on this technology can operate in extremely humid environments, in homecare, ambulatory services, and in hospitals. Microstream devices also offer improved moisture management to eliminate problems caused by blocked sample lines and in a nutshell, offer much more effective and stable monitoring.
In addition, capnography devices are now being developed as a measure of alveolar O2/CO2 exchange capabilities during the preliminary stages of treatment for chronic intubated and non-intubated patients. For instance, leading defibrillator manufacturers such as Zoll Medical and Medtronics Physio-Control now offer defibrillators that have capnograph-monitoring capabilities.
And lastly, recent improvements in end-tidal CO2 monitoring have resulted in the development of a non-invasive option capnography that can quickly note respiratory responses to administered medications.
Even more applications and improvements in capnography devices are in the pipeline, and expected to boost market demand and revenue to unprecedented heights. As is the case in any healthcare related technology market, constant advancement and evolution is key, and that’s one thing vendors in the Global Capnography Market are doing absolutely right.
For more information, view our 2012-2016 report on the Global Capnography Market.
